4 ms·
> inhibitor > agonist nit: these are not the same Also, not all thyroid cancers are created equally (like papillary vs medullary), not every one taking GLP-1
by ZYbCRq22HbJ2y7 2y ago
> inhibitor
> agonist
nit: these are not the same
Also, not all thyroid cancers are created equally (like papillary vs medullary), not every one taking GLP-1 RAs are morbidly obese, etc.
- A_D_E_P_T 2y agoExcuse the mix-up. > Also, not all thyroid cancers are created equally (like papillary vs medullary) Granted, but how is this relevant? I've heard that those drugs may -- this is still, as yet, uncertain -- increase the likelihood of follicular thyroid cancer, which is a very weak type. I have not heard that they increase one's likelihood of coming down with the anaplastic variant. (The only truly deadly one, but quite rare.) If caught early enough, papillary, follicular, and medullary are all easily treatable and indeed curable. > not every one taking GLP-1 RAs are morbidly obese Again, sure, but how is it relevant?